Sort
15,842 grants matching “pancreatic cancer”
Preclinical Studies on Polyunsaturated Fatty Acid-Taxoid Conjugate for IND Filing
$656,011Ramesh Chander Gupta · Chem-Master International, Inc · R44 · FY2010 · CA
Novel Therapy to Inhibit IPMN Progression
$655,860Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Project 1: Targeting Oncogenic Transcription Factors
$655,771Christopher Vakoc · Cold Spring Harbor Laboratory · P01 · FY2024 · CA
Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer
$655,693Eric Collisson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Inhibiting Multi-Functional ALDOA for Cancer Therapy
$655,553Garth Powis · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2018 · CA
Mitochondrial calcium signaling in pancreatic cancer metastasis and progression
$655,433Shengyu Yang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
$655,269Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Disparities in access to and outcomes of cancer surgery for rural Medicare patients
$655,190Anna N. A. Tosteson · Dartmouth College · R01 · FY2021 · CA
Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol
$654,995Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2008 · CA
Flexible Tools for Pre-Clinical Studies to Answer Key Questions UnderlyingHeavy-Ion Radiotherapy
$654,731David Jonathan Brenner · Columbia University Health Sciences · U01 · FY2020 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,726Robert H Vonderheide · University Of Pennsylvania · P01 · FY2018 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,726Robert H Vonderheide · University Of Pennsylvania · P01 · FY2017 · CA
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma
$654,706Timothy A Marlowe · Faknostics, Llc · R42 · FY2023 · CA
Anticancer ELNP nanovaccines for curative treatmentof pancreatic cancer
$654,681Zheng-Rong Lu · Case Western Reserve University · R01 · FY2025 · CA
A novel diagnostic biomarker for Hepatocellular Carcinoma(HCC)
$654,671Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2017 · CA
Dietary Regulation of Intestinal Inflammation and Repair
$654,662David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK
Pancreatic cancer patient-derived xenograft tumors for translational studies in precision cancer medicine
$654,197Andrew Liss · Massachusetts General Hospital · R01 · FY2025 · CA
Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study
$654,143Allison W. Kurian · Stanford University · R01 · FY2025 · CA
Signal Transduction by Tyrosine Phosphorylation
$654,096Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2019 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$654,058Robert H Vonderheide · University Of Pennsylvania · P01 · FY2019 · CA
Center for Functional Validation and Evaluation of ENCODE Enhancer Regions
$654,000Kevin P White · University Of Chicago · UM1 · FY2017 · HG
Improving Management of patients at High Risk of Pancreatic Cancer
$653,819Alison P Klein · Johns Hopkins University · R01 · FY2025 · CA
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology
$653,811Jennifer B Permuth · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2023 · CA
Imaging Modulation of Immune Phenotype
$653,804Katherine W Ferrara · Stanford University · R01 · FY2025 · CA
Causes and Consequences of Adenosine Signaling in Pancreatic Cancer
$653,625Timothy R Donahue · University Of California Los Angeles · R01 · FY2025 · CA